z-logo
Premium
Virus Inactivation by Solvent/Detergent Treatment and the Manufacture of SD‐Plasma
Author(s) -
Horowitz B.,
Lazo A.,
Grossberg H.,
Page G.,
Lippin A.,
Swan G.
Publication year - 1998
Publication title -
vox sanguinis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.68
H-Index - 83
eISSN - 1423-0410
pISSN - 0042-9007
DOI - 10.1111/j.1423-0410.1998.tb05473.x
Subject(s) - virus inactivation , fresh frozen plasma , medicine , virus , viral envelope , blood product , virology , convalescent plasma , chemistry , surgery , immunology , covid-19 , platelet , disease , infectious disease (medical specialty)
Solvent/Detergent (SD) is an extraordinarily effective means for eliminating enveloped viruses from plasma and plasma products [1]. The safety margin suggested by the rapid and complete kill of enveloped viruses observed in the laboratory has been confirmed repeatedly by groups worldwide and by thirteen years of routine clinical use encompassing an estimated 35 million doses of a wide variety of products. Throughout this time, there has not been a single documented case of enveloped virus transmission by an SD‐treated product. This record of safety spawned the development of SD‐treated plasma as a substitute for fresh frozen plasma (FFP) [2] and has encouraged the adoption of SD for the treatment of non‐blood products such as monoclonal antibodies and those derived from recombinant DNA procedures [3]. This review summarizes the use of SD treatment, including its use in combination with other viral elimination procedures, and also summarizes Vitex's initial experience in the manufacture of SD‐Plasma, recently licensed by the U.S. FDA.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom